A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia
Status:
Completed
Trial end date:
2015-06-30
Target enrollment:
Participant gender:
Summary
The purposes of this study are to provide medical management by giving treatment to the
mother that will bring up the fetal platelet count and to minimize the number of invasive
procedures to the fetus (which may result in serious fetal injuries).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Weill Medical College of Cornell University
Collaborators:
Columbia University New York Presbyterian Hospital